A novel treatment strategy could overcome drug resistance in testicular cancer, find out exclusive details in this interview with study leader Janet Shipley from the ICR (London, UK).
Browsing: Taxonomy > Biological and targeted therapies
In this joint interview we delve deeper into the news story to find out both the clinician’s and patient’s perspective on the recent recommendation of ixazomib for NHS distribution.
John Ellwood discusses the treatment he underwent following his diagnosis with myeloma.
To mark International Women’s Day we recently spoke with Victoria Sanz Moreno from Kings College London (UK) to find out what inspired her to get into cancer research.
To mark Rare Disease Day we recently spoke with Jonathan Wadsley (Weston Park Hospital, Sheffield, UK) about recent advancements in care for medullary thyroid cancer.
Discover details of the first randomized, multicenter Phase III study to compare the safety and efficacy of mirvetuximab soravtansine vs investigator’s choice of chemotherapy in women with folate receptor-α-positive, platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.
Results from a pair of clinical trials evaluating the CAR-T cell therapy Kymriah™ have demonstrated long-lasting remissions in non-Hodgkin’s lymphoma patients.
In this research article from the Journal of Comparative Effectiveness Research find out about the characteristics and treatment patterns among US patients with hairy cell leukemia.